The Securities Law Firm of Menzer & Hill, P.A. Announces Investigation of John Carris Investments, L

The Securities Law Firm of Menzer & Hill, P.A. Announces Investigation of John Carris Investments, LLC and Fibrocell Science, Inc.

BOCA RATON, Fla.--(BUSINESS WIRE)-- The Securities Law Firm of Menzer & Hill, P.A. (www.suemyadvisor.com) announced today that it is investigating John Carris Investments, LLC related to trading involving the security Fibrocell Science, Inc. ("Fibrocell") (NYS: FCSC) . Last month the Financial Industry Regulatory Authority Inc. ("FINRA") filed a complaint against John Carris Investments and its founder alleging the Firm engaged in, "a course of misconduct which included stock manipulation, fraudulent and unsuitable self-offerings of securities, operating a securities business without sufficient net capital, use of Firm funds to pay personal expenses of Firm principals..."

The alleged manipulative stock trading involved Fibrocell, which John Carris Investments was acting as a placement agent for. The complaint further alleges that the Firm defrauded customers in connection with the sale of stock and notes in the Firm's parent company, Invictus Capital, Inc.

Additionally, the Firm was allegedly selling personal shares in Fibrocell, while the Firm was soliciting its customers to buy shares in the company.

Investors that maintained investment accounts with John Carris Investments or that owned shares in Fibrocell should contact the attorneys at the Securities Law Firm of Menzer & Hill, P.A. to determine if they have a claim for a recovery of losses.

For a free case evaluation or to discuss any other investment losses, please contact the Securities Law Firm of Menzer & Hill, P.A., at 888-923-9223, or visit us on the web at www.suemyadvisor.com.

Law Firm of Menzer & Hill, P.A.
Gary Menzer, 888-923-9223

KEYWORDS: United States North America Florida

INDUSTRY KEYWORDS:

The article The Securities Law Firm of Menzer & Hill, P.A. Announces Investigation of John Carris Investments, LLC and Fibrocell Science, Inc. originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.